biologic
-
Spine
HippoFi’s Regenerative Therapeutics Division Launches PURbridge™ for Spine Surgery
PURbridge™, an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company’s revenue throughout 2023…
Read More » -
Biologics
NICE widens biologic options for spinal arthritis
By Selina Mckee Patients in England and Wales with ankylosing spondylitis could soon routinely access a wider list of biologic…
Read More » -
Biologics
Biologic Treatments for OA: A Sports Medicine Perspective
By Bert Mandelbaum, MD A Comprehensive Approach to Knee Osteoarthritis To be a good surgeon these days, you can’t just…
Read More » -
Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis
San Francisco, CA (PRWEB) March 23, 2010 — Biologic Joint Reconstruction, rather than bionic (artificial) replacement, may be an appropriate…
Read More » -
SANUWAVE Health Reports 2009 Third Quarter Results
ALPHARETTA, Ga.–(BUSINESS WIRE)–SANUWAVE Health, Inc., (OTC BB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization…
Read More » -
Medtronic launches Mastergraft Strip in US
Nov 13, 2009 (Datamonitor via COMTEX) — MDT | Quote | Chart | News | PowerRating — Medtronic, a medical…
Read More » -
Bio-resorbable screws screws used for surgery
Chennai, Nov 10: Apollo Hospitals here has used bio-resorbable screws for surgery recently on six-year-old child. “Conducted on 24 October,…
Read More » -
Stematix™ Obtains Exclusive License to Regenexx™ Stem Cell Procedure Treating Musculoskeletal Diseases in Latin America
Houston, TX (PRWEB) October 23, 2009 — Stematix Inc., announced today it has signed an exclusive royalty-bearing license agreement, for…
Read More » -
Genzyme Reports Third-Quarter Financial Results
Genzyme Corp. (NASDAQ: GENZ) today reported that third-quarter revenue was $1.06 billion, compared with $1.16 billion in the same period…
Read More » -
BioCeramic Therapeutics Raises £1.2 Million
BioCeramic Therapeutics (BCT), an emerging leader in the field of novel biomaterials for healthcare, has received £1.2 million of new…
Read More » -
MiMedx Group Sells Upper Extremities Business
ATLANTA–(BUSINESS WIRE)–MiMedx Group, Inc. (OTCBB:MDXG – News) (the “Company”) announced today that it has sold the assets of its upper…
Read More »